LeadershipAdvocacy & Gov't AffairsHistoryCareers at Joslin
Newly DiagnosedManaging DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsJoslin Clinical ResearchInfo for Healthcare ProfessionalsJoslin Clinical Guidelines
Adult ClinicYoung Adult Transition CarePediatricsEye CareWeight Management ProgramsDO ITMental Health & CounselingReferring PhysiciansBillingAsian ClinicLatino Diabetes InitiativeAbout Joslin ResearchVolunteer for Clinical Research StudiesInfo for Healthcare ProfessionalsClinical Guidelines
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside Joslin
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalCause MarketingCommercialization and VenturesHealthcare Professionals
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Dan Anderson, Ph.D.

Dr. Anderson has spent the last 10 years developing non-viral gene delivery agents.  These studies have resulted in delivery materials with excellent gene delivery performance in vitro and in vivo.  Products based on these materials have been commercialized specifically to transfect stem cells (Stemfect from Stemgent, Xfect from Clonetech).  He has also spent significant effort towards the in vivo application of DNA and RNA delivery systems, and have demonstrated delivery efficacy in a variety of species, including primates. 

Page last updated: April 24, 2014